Large Cap Biopharmaceuticals: Updates on #ASCO24 Week…Update-2
Update-2 Biopharma rally moves to SMID caps as momentum picks up ADPT, NVAX, TWST etc XBI over $93. Large caps steady with REGN over $1000. POST ASCO large cap core portfolio picks: ABBV, AZN, LLY, MRK, REGN. VRTX. Pfizer had good results but the stock could not break $30 so my calls with...
Life Science Momentum Trades In a Volatile Market…Update-6…..Many big winners
Update: 6/7/24.,,Our model still looks good for experienced traders.Today for example GERON (GERN) soared 19% with approval of RYTELO for MDS associated anemia. We will summarize news from winning stocks over the weekend. XBI was weak today down about 1% to $91 handle. Strong jobs could mean...
Large Cap Biopharmaceuticals Performance…Update-3 #ASCO24 gains are ahead
UPDATE 3: Large cap biopharmas were strong on Friday in anticipation of #ASCO24 data. Company news to watch from data below:AZN, BMY, GILD, LLY, MRK, PFE,REGN and also ADPT, MRUS, NVS. REPL.. See updates all next week. Update-2 MAY 31,,,Biopharma stocks took a dip midweek during FED speak then...
SMID Life Science Trades that Picked Up MOMENTUM…Update-4…nothing
Update-4 5/23/24...XBI down 3% to $89 handle, rates up =risk off, But S&P hold 5200. NVDA rules nothing else in broad sell-off. Update-3 5/22...XBI is holding the $92 level and several SMID stocks show gains:ADPT, CRNX,CRSP, PACB, TXG. NTRA near 52 wet high of $110. NVAX up 13% to $16.84...
Healthcare and Biotech Investing 101: What you need to know.
Healthcare and Biotech Investing 101: What you need to know. What is your current allocation for healthcare stocks? Large cap stocks that pay dividends are the best positioned for growth plus value. Start with an ETF plus one Fund. If you have been reading our artlcles you already know some of...